Thomas Kabir

7.4k total citations
39 papers, 444 citations indexed

About

Thomas Kabir is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Social Psychology. According to data from OpenAlex, Thomas Kabir has authored 39 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 16 papers in Experimental and Cognitive Psychology and 9 papers in Social Psychology. Recurrent topics in Thomas Kabir's work include Schizophrenia research and treatment (22 papers), Mental Health Research Topics (11 papers) and Psychosomatic Disorders and Their Treatments (8 papers). Thomas Kabir is often cited by papers focused on Schizophrenia research and treatment (22 papers), Mental Health Research Topics (11 papers) and Psychosomatic Disorders and Their Treatments (8 papers). Thomas Kabir collaborates with scholars based in United Kingdom, Australia and New Zealand. Thomas Kabir's co-authors include Daniel Freeman, Felicity Waite, Chris Hollis, E Bethan Davies, André Tomlin, Lucy Simons, Toto Gronlund, Tania Gergel, Debbie Butler and Victoria Betton and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Psychological Medicine.

In The Last Decade

Thomas Kabir

33 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Kabir United Kingdom	12	143	131	130	119	94	39	444
Christian Rauschenberg United Kingdom	13	164 1.1×	321 2.5×	115 0.9×	168 1.4×	80 0.9×	25	578
Rohan Morris United Kingdom	8	334 2.3×	94 0.7×	136 1.0×	177 1.5×	126 1.3×	16	458
Jonathan Ward United Kingdom	15	199 1.4×	264 2.0×	246 1.9×	124 1.0×	165 1.8×	38	683
Carla McEnery Australia	12	308 2.2×	219 1.7×	125 1.0×	203 1.7×	87 0.9×	24	562
Whitney C. Brown United States	13	115 0.8×	310 2.4×	52 0.4×	218 1.8×	69 0.7×	21	537
Denis G. Birgenheir United States	11	37 0.3×	221 1.7×	167 1.3×	68 0.6×	78 0.8×	16	430
F. Katharina Reichelt United Kingdom	8	63 0.4×	336 2.6×	150 1.2×	106 0.9×	63 0.7×	11	564
Hubert Suszek Poland	11	33 0.2×	244 1.9×	126 1.0×	146 1.2×	80 0.9×	42	491
Greg Haggerty United States	11	65 0.5×	264 2.0×	52 0.4×	61 0.5×	56 0.6×	32	404
Wendy Wade United States	6	116 0.8×	496 3.8×	83 0.6×	229 1.9×	132 1.4×	9	680

Countries citing papers authored by Thomas Kabir

Since Specialization

Citations

This map shows the geographic impact of Thomas Kabir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kabir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kabir more than expected).

Fields of papers citing papers by Thomas Kabir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kabir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kabir. The network helps show where Thomas Kabir may publish in the future.

Co-authorship network of co-authors of Thomas Kabir

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kabir. A scholar is included among the top collaborators of Thomas Kabir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kabir. Thomas Kabir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watson, Stuart, Niraj Ahuja, Andrea Cipriani, et al.. (2025). Reducing the Delay in the Diagnosis of Bipolar Disorder: A Qualitative Study. Health Expectations. 28(4). e70398–e70398.

Kabir, Thomas, et al.. (2025). Clozapine: old drugs require efforts to improve patient experience and access. The Lancet. 405(10497). 2259–2261.

Hall, Charlotte L, Aislinn Bergin, Pamela Jacobsen, et al.. (2024). Developing a process for assessing the safety of a digital mental health intervention and gaining regulatory approval: a case study and academic’s guide. Trials. 25(1). 604–604. 3 indexed citations

Kabir, Thomas, Maurice Arbuthnott, Sarah Nettleton, et al.. (2024). Potential research priorities for understanding and treating severe paranoia (persecutory delusions): a priority-setting partnership between patients, carers, mental health staff, and researchers. SHILAP Revista de lepidopterología. 27(1). e301224–e301224.

Rosebrock, Laina, et al.. (2024). Developing an Automated Virtual Reality Therapy for Improving Positive Self-Beliefs and Psychological Well-Being (Phoenix VR Self-Confidence Therapy): Tutorial. JMIR Serious Games. 12. e51512–e51512. 1 indexed citations

Waite, Felicity, et al.. (2024). Framework for understanding movement and physical activity in patients diagnosed with psychosis. SHILAP Revista de lepidopterología. 27(1). e300878–e300878. 4 indexed citations

Watson, Stuart, et al.. (2024). Aripiprazole/Sertraline Combination: Clinical and Cost‐Effectiveness in Comparison With Quetiapine for the Treatment of Bipolar Depression (ASCEnD Trial)—Protocol for a Nested Qualitative Study. Health Expectations. 27(5). e70018–e70018. 1 indexed citations

Freeman, Daniel, Jason Freeman, Aitor Rovira, et al.. (2023). Randomised controlled trial of automated VR therapy to improve positive self-beliefs and psychological well-being in young people diagnosed with psychosis: a study protocol for the Phoenix VR self-confidence therapy trial. BMJ Open. 13(12). e076559–e076559. 3 indexed citations

Carr, Matthew, Darren M. Ashcroft, Carolyn Chew‐Graham, et al.. (2023). Temporal trends in eating disorder and self-harm incidence rates among adolescents and young adults in the UK in the 2 years since onset of the COVID-19 pandemic: a population-based study. The Lancet Child & Adolescent Health. 7(8). 544–554. 45 indexed citations

10.

Hsu, Che-Wei, Daniel Ståhl, Elias Mouchlianitis, et al.. (2023). User-Centered Development of STOP (Successful Treatment for Paranoia): Material Development and Usability Testing for a Digital Therapeutic for Paranoia. JMIR Human Factors. 10. e45453–e45453. 4 indexed citations

11.

Yiend, Jenny, Margaret Heslin, Thomas Kabir, et al.. (2022). Cognitive bias modification for paranoia (CBM-pa): a randomised controlled feasibility study in patients with distressing paranoid beliefs. Psychological Medicine. 53(10). 4614–4626. 11 indexed citations

12.

Freeman, Daniel, Sinéad Lambe, Ushma Galal, et al.. (2022). Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial. Schizophrenia Research. 250. 50–59. 5 indexed citations

13.

Wykes, Til, Andy Bell, Sarah Carr, et al.. (2021). Shared goals for mental health research: what, why and when for the 2020s. Journal of Mental Health. 32(6). 997–1005. 32 indexed citations

14.

Robotham, Dan, Alex Kenny, Vanessa Pinfold, et al.. (2021). Automated Virtual Reality Cognitive Therapy for People With Psychosis: Protocol for a Qualitative Investigation Using Peer Research Methods. JMIR Research Protocols. 10(10). e31742–e31742. 3 indexed citations

15.

Lambe, Sinéad, Jessica C. Bird, Bao Sheng Loe, et al.. (2021). The Oxford Agoraphobic Avoidance Scale. Psychological Medicine. 53(4). 1233–1243. 11 indexed citations

16.

Lambe, Sinéad, Thomas Kabir, Jonathan West, et al.. (2020). Developing an automated VR cognitive treatment for psychosis: gameChange VR therapy. Royal College of Art Research Repository (Royal College of Art). 30(1). 33–40. 28 indexed citations

17.

Sheaves, Bryony, et al.. (2020). Why do patients with psychosis listen to and believe derogatory and threatening voices? 21 reasons given by patients. Behavioural and Cognitive Psychotherapy. 48(6). 631–645. 6 indexed citations

18.

Waite, Felicity, Thomas Kabir, Louise Johns, et al.. (2020). Treating sleep problems in young people at ultra-high-risk of psychosis: study protocol for a single-blind parallel group randomised controlled feasibility trial (SleepWell). BMJ Open. 10(11). e045235–e045235. 8 indexed citations

19.

Leung, Constant, Johanna Frerichs, Margaret Heslin, et al.. (2019). A qualitative study of the acceptability of cognitive bias modification for paranoia (CBM-pa) in patients with psychosis. BMC Psychiatry. 19(1). 225–225. 10 indexed citations

20.

Yiend, Jenny, Antonella Trotta, Thomas Kabir, et al.. (2017). Cognitive Bias Modification for paranoia (CBM-pa): study protocol for a randomised controlled trial. Trials. 18(1). 298–298. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact